Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

523
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
523
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

679
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
679
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

1.0K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

721
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
721
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.5K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

842
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
842

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Facing the fifties... The male point of view.

Canadian family physician Medecin de famille canadien·2011
Same author

Setting goals for family practice departments.

Canadian family physician Medecin de famille canadien·2011
Same author

Behavioral medicine and university departments of family practice.

Canadian family physician Medecin de famille canadien·2010
Same author

Reducing pathology test misuse.

Australian health review : a publication of the Australian Hospital Association·1992
Same author

Practice patterns of family physicians with 2-year residency v. 1-year internship training: do both roads lead to Rome?

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·1989
Same author

Effects of substance P and neurokinin A (substance K) on motor behavior: unique effect of substance P attributable to its amino-terminal sequence.

Brain research·1987

Related Experiment Video

Updated: Mar 17, 2026

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.8K

Traveler's Diarrhea in Athletes.

P Grantham

    The Physician and Sportsmedicine
    |July 28, 2016
    PubMed
    Summary

    Traveler's diarrhea affects 30-60% of international athletes, often caused by enterotoxigenic Escherichia coli. Doxycycline shows promise for prophylaxis, while treatment focuses on symptom relief and improved stool consistency.

    Area of Science:

    • Infectious Diseases
    • Travel Medicine
    • Microbiology

    Background:

    • Traveler's diarrhea (TD) is a frequent health issue for international athletes.
    • Incidence rates of TD range from 30% to 60% in studied traveling groups.
    • Enterotoxigenic Escherichia coli (ETEC) is identified as the predominant pathogen causing TD.

    Purpose of the Study:

    • To review the commonality and causative agents of traveler's diarrhea in athletes.
    • To evaluate the efficacy of doxycycline as a prophylactic measure against ETEC infections.
    • To outline current treatment strategies for managing traveler's diarrhea.

    Main Methods:

    • Review of existing literature and clinical experience regarding traveler's diarrhea.
    • Analysis of pathogen prevalence, with a focus on enterotoxigenic Escherichia coli.

    More Related Videos

    A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
    06:55

    A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

    Published on: November 7, 2018

    9.5K
    Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
    07:06

    Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

    Published on: December 8, 2014

    27.8K

    Related Experiment Videos

    Last Updated: Mar 17, 2026

    Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
    03:25

    Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

    Published on: December 27, 2024

    1.8K
    A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
    06:55

    A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

    Published on: November 7, 2018

    9.5K
    Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
    07:06

    Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

    Published on: December 8, 2014

    27.8K
  • Assessment of doxycycline's effectiveness in preventing ETEC infections.

    • Main Results:

    • Enterotoxigenic Escherichia coli is the most frequent cause of traveler's diarrhea.
    • Doxycycline has demonstrated effectiveness in providing prophylaxis against ETEC in various international settings.
    • Treatment protocols aim to alleviate discomfort, normalize stool consistency, and decrease stool frequency.

    Conclusions:

    • Traveler's diarrhea is a significant concern for athletes undertaking international travel.
    • Doxycycline is a viable option for the prevention of ETEC-related traveler's diarrhea.
    • Symptomatic management remains a key component in treating traveler's diarrhea.